Poland· PL-100204946
Bilobil Forte
A ginkgoblatt product containing ginkgo bilobae folii extractum, registered in Poland by Krka, d.d., Novo mesto. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Ginkgoblatt is registered in 6 of 19 countries.
Countries holding a registration under ATC N06DX02 (ginkgoblatt), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Ginkgoblatt · ATC N06DX02
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Ginkgo bilobae folii extractum
- Manufacturer
- Krka, d.d., Novo mesto
- Country
- Poland (PL)
- ATC code
- N06DX02
- ATC class
- Ginkgoblatt
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990646609
- gtin05909991059415
- gtin05909991059422
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
22 interactions on record for ginkgoblatt.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ginkgoblatt · interactions on record
22 records
22 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under N06DX02
Ginkgoblatt, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/94087eb1-b05a-4144-8bcd-4f2360ee484a GET /v1/drugs/94087eb1-b05a-4144-8bcd-4f2360ee484a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "19,2-23,2 mg glikozydów flawonowych i 4,8-7,2 mg terpentów laktonowych/kapsułkę",
"packaging": "05909990646609 ¦ OTC ¦ 22984\n90 kaps.\n05909991059415 ¦ OTC ¦ 23153\n20 kaps.\n05909991059422 ¦ OTC ¦ 23154\n60 kaps.",
"substance": "Ginkgo bilobae extractum (35-67:1) 80 mg;",
"common_name": "Ginkgo bilobae folii extractum",
"pl_product_id": "100204946",
"pozwolenie_nr": "10594",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about ginkgoblatt.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.